MIMEDX GROUP, INC. (MDXG) Financials
Annual revenue, profitability and per-share results for MIMEDX GROUP, INC., as reported in SEC filings.
Revenue • FY2025
$418.63M
▲ 20.0%YoY
Net income • FY2025
$48.58M
▲ 14.5%YoY
Gross margin • FY2025
82.6%
Diluted EPS • FY2025
$0.32
▲ 14.3%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $418.63M | $48.58M | $345.62M | $0.32 | — | 15.3% | +20.0% |
| FY2024 | $348.88M | $42.42M | $288.81M | $0.28 | — | 16.9% | +8.5% |
| FY2023 | $321.48M | $58.23M | $266.84M | $0.37 | $32.95M | 11.6% | +20.0% |
| FY2022 | $267.84M | -$30.2M | $219.53M | -$0.33 | — | -9.3% | +3.6% |
Figures as reported in MIMEDX GROUP, INC.'s 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Financials for companies related to MDXG
Never miss a MDXG filing.
Get an email when MDXG files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.